PRESS RELEASE published on 05/06/2024 at 23:25, 2 years ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 2 years 1 month ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 2 years 1 month ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 2 years 1 month ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 2 years 2 months ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 2 years 2 months ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 2 years 2 months ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 3 years 2 months ago Love Pharma Inc. Announces Share Consolidation
Published on 05/22/2026 at 14:04, 8 hours 17 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 8 hours 21 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 8 hours 21 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 8 hours 21 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 22:05, 16 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 16 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 2 hours 29 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 3 hours 48 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 3 hours 50 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 2 hours 46 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 4 hours 15 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 4 hours 15 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 9 hours 28 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 9 hours 28 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
